Variant report

Variant	nsv1051623
Chromosome Location	chr13:67377549-67465276
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:268)
CpG islands
(count:122)
Chromatin interactive
region (count:6)
LncRNA
region (count:7)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:268 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr13:67409290-67409647	K562	blood:	n/a	n/a
2	CBX3	chr13:67385534-67385881	K562	blood:	n/a	n/a
3	CEBPB	chr13:67456481-67456509	IMR90	lung:	n/a	n/a
4	CEBPB	chr13:67379741-67380150	Hela-S3	cervix:	n/a	chr13:67379983-67379994
5	CEBPB	chr13:67378268-67378811	Hela-S3	cervix:	n/a	chr13:67378729-67378740 chr13:67378729-67378740 chr13:67378544-67378557 chr13:67378441-67378458
6	CEBPB	chr13:67394912-67395112	HepG2	liver:	n/a	n/a
7	CEBPB	chr13:67421612-67422123	A549	lung:	n/a	n/a
8	CEBPB	chr13:67379693-67380116	A549	lung:	n/a	chr13:67379983-67379994
9	CEBPB	chr13:67421847-67422047	A549	lung:	n/a	n/a
10	CEBPB	chr13:67429391-67429576	A549	lung:	n/a	n/a
11	CEBPB	chr13:67394952-67395122	A549	lung:	n/a	n/a
12	CTCF	chr13:67409340-67409490	HBMEC	blood vessel:	n/a	n/a
13	CTCF	chr13:67420981-67421059	LNCaP	prostate:	n/a	n/a
14	CTCF	chr13:67409600-67409750	BE2_C	brain:	n/a	n/a
15	CTCF	chr13:67463855-67463909	Kidney_OC	kidney:	n/a	n/a
16	CTCF	chr13:67435100-67435250	GM12871	blood:	n/a	n/a
17	CTCF	chr13:67424096-67424113	HepG2	liver:	n/a	n/a
18	CTCF	chr13:67409680-67409830	A549	lung:	n/a	n/a
19	CTCF	chr13:67405780-67405930	HRE	kidney:	n/a	n/a
20	CTCF	chr13:67387060-67387210	NB4	blood:	n/a	n/a
21	CTCF	chr13:67409240-67409390	GM12875	blood:	n/a	n/a
22	CTCF	chr13:67409620-67409770	BE2_C	brain:	n/a	n/a
23	CTCF	chr13:67409620-67409770	HEK293	kidney:	n/a	n/a
24	CTCF	chr13:67424040-67424190	GM12867	blood:	n/a	n/a
25	CTCF	chr13:67394999-67395078	GM10248	blood:	n/a	n/a
26	CTCF	chr13:67409300-67409450	SK-N-SH_RA	brain:	n/a	n/a
27	CTCF	chr13:67409600-67409750	HPF	lung:	n/a	n/a
28	CTCF	chr13:67409600-67409750	AoAF	blood vessel:	n/a	n/a
29	CUX1	chr13:67438613-67438637	K562	blood:	n/a	n/a
30	CUX1	chr13:67420153-67420166	K562	blood:	n/a	n/a
31	E2F4	chr13:67404479-67404547	MCF10A-Er-Src	breast:	n/a	n/a
32	E2F4	chr13:67410109-67410314	MCF10A-Er-Src	breast:	n/a	n/a
33	E2F4	chr13:67432774-67432869	MCF10A-Er-Src	breast:	n/a	n/a
34	E2F4	chr13:67403495-67403634	MCF10A-Er-Src	breast:	n/a	n/a
35	ELK1	chr13:67405194-67405210	Hela-S3	cervix:	n/a	n/a
36	EP300	chr13:67461110-67461545	SK-N-SH_RA	brain:	n/a	chr13:67461402-67461416
37	EP300	chr13:67378317-67378777	Hela-S3	cervix:	n/a	n/a
38	EP300	chr13:67409306-67409668	K562	blood:	n/a	n/a
39	EP300	chr13:67409239-67409712	SK-N-SH_RA	brain:	n/a	n/a
40	EP300	chr13:67409195-67409689	SK-N-SH_RA	brain:	n/a	n/a
41	EP300	chr13:67421533-67422102	A549	lung:	n/a	n/a
42	EP300	chr13:67460458-67460724	SK-N-SH_RA	brain:	n/a	n/a
43	EP300	chr13:67379851-67380143	SK-N-SH_RA	brain:	n/a	n/a
44	EP300	chr13:67421519-67422049	A549	lung:	n/a	n/a
45	EP300	chr13:67379806-67380113	SK-N-SH_RA	brain:	n/a	n/a
46	EP300	chr13:67409076-67409697	A549	lung:	n/a	n/a
47	EP300	chr13:67405609-67406005	SK-N-SH_RA	brain:	n/a	n/a
48	EP300	chr13:67379768-67380155	Hela-S3	cervix:	n/a	n/a
49	EP300	chr13:67461263-67461556	SK-N-SH_RA	brain:	n/a	chr13:67461402-67461416
50	ESR1	chr13:67383550-67383906	ECC-1	luminal epithelium:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr13:67421996-67422046	HPAEpiC	pulmonary alveolar:	n/a
2	chr13:67421996-67422046	NB4	blood:	n/a
3	chr13:67434423-67434473	HRCEpiC	kidney:	n/a
4	chr13:67421996-67422046	BE2_C	brain:	n/a
5	chr13:67434423-67434473	NHBE	bronchial:	n/a
6	chr13:67421996-67422046	AoSMC	blood vessel:	n/a
7	chr13:67421996-67422046	HEEpiC	esophagus:	n/a
8	chr13:67421996-67422046	LNCaP	prostate:	n/a
9	chr13:67434423-67434473	HPAEpiC	pulmonary alveolar:	n/a
10	chr13:67421996-67422046	NT2-D1	testis:	n/a
11	chr13:67434423-67434473	HUVEC	blood vessel:	n/a
12	chr13:67434423-67434473	NB4	blood:	n/a
13	chr13:67434423-67434473	ECC-1	luminal epithelium:	n/a
14	chr13:67434423-67434473	HCF	heart:	n/a
15	chr13:67421996-67422046	AG04450	lung:	fetal
16	chr13:67434423-67434473	ProgFib	skin:	n/a
17	chr13:67434423-67434473	PANC-1	pancreas:	n/a
18	chr13:67421996-67422046	IMR90	lung:	fetal
19	chr13:67421996-67422046	SKMC	muscle:	n/a
20	chr13:67434423-67434473	NHDF-neo	bronchial:	n/a
21	chr13:67421996-67422046	HNPCEpiC	eye:	n/a
22	chr13:67421996-67422046	MCF-7	breast:	n/a
23	chr13:67421996-67422046	HCPEpiC	choroid plexus:	n/a
24	chr13:67434423-67434473	HAEpiC	amniotic membrane:	n/a
25	chr13:67434423-67434473	T-47D	breast:	n/a
26	chr13:67434423-67434473	HEEpiC	esophagus:	n/a
27	chr13:67421996-67422046	SK-N-SH_RA	brain:	n/a
28	chr13:67434423-67434473	AG04450	lung:	fetal
29	chr13:67434423-67434473	HepG2	liver:	n/a
30	chr13:67434423-67434473	H1-hESC	embryonic stem cell:	embryo
31	chr13:67434423-67434473	NT2-D1	testis:	n/a
32	chr13:67434423-67434473	ovcar-3	ovarian:	n/a
33	chr13:67434423-67434473	CMK	blood:	n/a
34	chr13:67434423-67434473	A549	lung:	n/a
35	chr13:67434423-67434473	AG04449	skin:	fetal
36	chr13:67421996-67422046	GM06990	blood:	n/a
37	chr13:67421996-67422046	HL-60	blood:	n/a
38	chr13:67421996-67422046	Hepatocyte	liver:	n/a
39	chr13:67434423-67434473	GM06990	blood:	n/a
40	chr13:67434423-67434473	BE2_C	brain:	n/a
41	chr13:67421996-67422046	HMEC	breast:	n/a
42	chr13:67421996-67422046	HRCEpiC	kidney:	n/a
43	chr13:67421996-67422046	NHBE	bronchial:	n/a
44	chr13:67434423-67434473	U87	brain:	n/a
45	chr13:67434423-67434473	Hela-S3	cervix:	n/a
46	chr13:67434423-67434473	HCPEpiC	choroid plexus:	n/a
47	chr13:67434423-67434473	HEK293	kidney:	embryo
48	chr13:67421996-67422046	HCF	heart:	n/a
49	chr13:67434423-67434473	HCT-116	colon:	n/a
50	chr13:67434423-67434473	HMEC	breast:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr13:67437418..67439470-chr13:67442003..67443610,2	MCF-7	breast:
2	chr13:67455570..67458044-chr13:67459396..67461929,2	MCF-7	breast:
3	chr13:67414851..67415422-chr7:70812042..70812870,2	MCF-7	breast:
4	chr13:67397391..67400012-chr13:67432704..67434627,2	K562	blood:
5	chr13:67455570..67458044-chr13:67459396..67461929,2	MCF-7	breast:
6	chr13:67437418..67439470-chr13:67442003..67443610,2	MCF-7	breast:

(count:7 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AL445989.1-14	chr13:67433120-67433252	ENSG00000228842.2
2	lnc-AL445989.1-14	chr13:67460132-67460209	ENSG00000228842.1
3	lnc-AL445989.1-14	chr13:67460132-67460208	ENSG00000228842.2
4	lnc-AL445989.1-14	chr13:67450976-67451051	ENSG00000228842.2
5	lnc-AL445989.1-14	chr13:67450976-67451051	ENSG00000228842.1
6	lnc-AL445989.1-14	chr13:67433130-67433252	ENSG00000228842.1
7	lnc-AL445989.1-14	chr13:67399301-67399368	ENSG00000228842.2

No data

Variant related genes	Relation type
PCDH9-AS2	TF binding region
PCDH9-AS2	CpG island
ENSG00000228842	chromatin interactions

Extended variants
information (count: 2242 )
Associated
traits (count: 98 )

Variant overlapped rSNPs/rCNVs (count:2242 , 50 per page) page: 1 2 3 4 5 6 7 ... 45

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs567405872	chr13:67377575-67377576	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs529333696	chr13:67377585-67377586	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs76921333	chr13:67377589-67377590	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs73210283	chr13:67377590-67377591	Weak transcription Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs571700911	chr13:67377641-67377642	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs186060693	chr13:67377647-67377648	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs112378016	chr13:67377649-67377650	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs58503433	chr13:67377700-67377701	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs539479683	chr13:67377713-67377714	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs556178070	chr13:67377806-67377807	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs151237807	chr13:67377865-67377866	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs140448085	chr13:67377889-67377890	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs75386423	chr13:67377896-67377897	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs535512933	chr13:67377907-67377908	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs557532875	chr13:67377930-67377931	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs542372416	chr13:67377965-67377966	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs1441998	chr13:67377967-67377968	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs1441997	chr13:67378060-67378061	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs4412870	chr13:67378063-67378064	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs571503666	chr13:67378064-67378065	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs558478410	chr13:67378085-67378086	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs577910288	chr13:67378092-67378093	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs190031157	chr13:67378096-67378097	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs9317615	chr13:67378152-67378153	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs145676911	chr13:67378195-67378196	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs543075284	chr13:67378225-67378226	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs181309928	chr13:67378249-67378250	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs573352675	chr13:67378252-67378253	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs527527697	chr13:67378254-67378255	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs547266455	chr13:67378268-67378269	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs377024073	chr13:67378275-67378276	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs540560568	chr13:67378305-67378306	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs370279396	chr13:67378331-67378332	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs570792295	chr13:67378336-67378337	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs565217348	chr13:67378337-67378338	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs185533977	chr13:67378356-67378357	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs549822496	chr13:67378379-67378380	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs114204116	chr13:67378481-67378482	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs535204890	chr13:67378515-67378516	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs146582431	chr13:67378593-67378594	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs35647128	chr13:67378595-67378596	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs190927272	chr13:67378623-67378624	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs371549835	chr13:67378677-67378678	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs558054884	chr13:67378697-67378698	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs577947663	chr13:67378738-67378739	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs373616502	chr13:67378742-67378743	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs182589959	chr13:67378787-67378788	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs556952382	chr13:67378806-67378807	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs76746675	chr13:67378830-67378831	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs532810636	chr13:67378836-67378837	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:98)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Squamous cell cancer	20885788	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	16573809	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Prostate cancer	17245344	CNVD
Prostate cancer	18632612	CNVD
Colorectal cancer	21586687	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Retinoblastoma	19183342	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Merkel cell carcinoma	19020549	CNVD
Basal cell lymphoma	17053054	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	21858162	CNVD
Glioblastoma multiforme	21922591	CNVD
Metanephric adenoma	20802469	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Gastric cancer	17908304	CNVD
Glioblastoma multiforme	21750150	CNVD
Breast cancer	17603634	CNVD
Cancer	21183584	CNVD
Breast cancer	17393978	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Liposarcoma	21253554	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Colorectal cancer	16774939	CNVD
Adenoid cystic carcinoma	17372589	CNVD
abnormal development	18461090	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Prostate cancer	16461572	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Schizophrenia	23813976	CNVD
Prostate cancer	22341455	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:469 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:67370400-67377600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr13:67375600-67378000	Weak transcription	H1 Cell Line	embryonic stem cell
3	chr13:67375800-67377600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
4	chr13:67375800-67383600	Weak transcription	Cortex derived primary cultured neurospheres	brain
5	chr13:67376400-67380600	Weak transcription	HUES48 Cell Line	embryonic stem cell
6	chr13:67377000-67377600	Enhancers	HUES6 Cell Line	embryonic stem cell
7	chr13:67377000-67381200	Enhancers	Brain Anterior Caudate	brain
8	chr13:67377200-67377600	Enhancers	Brain Hippocampus Middle	brain
9	chr13:67377200-67378000	Enhancers	iPS-18 Cell Line	embryonic stem cell
10	chr13:67377200-67378000	Enhancers	Brain Substantia Nigra	brain
11	chr13:67377200-67378200	Enhancers	Pancreatic Islets	Pancreatic Islet
12	chr13:67377200-67379200	Enhancers	Brain Cingulate Gyrus	brain
13	chr13:67377400-67377600	Enhancers	Brain Angular Gyrus	brain
14	chr13:67377400-67377600	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
15	chr13:67377400-67377800	Active TSS	Brain Inferior Temporal Lobe	brain
16	chr13:67377400-67378200	Enhancers	H9 Cell Line	embryonic stem cell
17	chr13:67377400-67378200	Enhancers	Fetal Brain Male	brain
18	chr13:67377400-67378200	Enhancers	Fetal Brain Female	brain
19	chr13:67377600-67377800	Flanking Active TSS	Brain Angular Gyrus	brain
20	chr13:67377600-67378000	Enhancers	Fetal Lung	lung
21	chr13:67377600-67378200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
22	chr13:67377600-67378200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
23	chr13:67377600-67378200	Flanking Active TSS	Brain Hippocampus Middle	brain
24	chr13:67377600-67378200	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
25	chr13:67377600-67378200	Enhancers	Fetal Muscle Leg	muscle
26	chr13:67377600-67378200	Enhancers	Left Ventricle	heart
27	chr13:67377600-67378200	Enhancers	Psoas Muscle	Psoas
28	chr13:67377600-67378600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
29	chr13:67377600-67380600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
30	chr13:67377800-67378000	Enhancers	Brain Angular Gyrus	brain
31	chr13:67377800-67378200	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
32	chr13:67378000-67378200	Enhancers	H1 Cell Line	embryonic stem cell
33	chr13:67378000-67378200	Flanking Active TSS	Brain Angular Gyrus	brain
34	chr13:67378000-67378200	Flanking Active TSS	Brain Substantia Nigra	brain
35	chr13:67378000-67378200	Flanking Active TSS	Fetal Lung	lung
36	chr13:67378000-67378400	Enhancers	Adipose Nuclei	Adipose
37	chr13:67378000-67378400	Enhancers	Skeletal Muscle Female	skeletal muscle
38	chr13:67378000-67378400	Enhancers	HSMMtube	muscle
39	chr13:67378000-67380000	Enhancers	Hela-S3	cervix
40	chr13:67378000-67380600	Enhancers	A549	lung
41	chr13:67378200-67378400	Enhancers	Muscle Satellite Cultured Cells	--
42	chr13:67378200-67378400	Enhancers	Brain Hippocampus Middle	brain
43	chr13:67378200-67378400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
44	chr13:67378200-67378600	Enhancers	Brain Substantia Nigra	brain
45	chr13:67378200-67378800	Enhancers	Brain Angular Gyrus	brain
46	chr13:67378200-67380000	Enhancers	Brain Inferior Temporal Lobe	brain
47	chr13:67378200-67380800	Enhancers	Fetal Lung	lung
48	chr13:67378400-67378800	Weak transcription	Brain Hippocampus Middle	brain
49	chr13:67378400-67379400	Weak transcription	Adipose Nuclei	Adipose
50	chr13:67378400-67379600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links